Frequency of chronic headaches in japanese patients with multiple sclerosis: With special reference to opticospinal and common forms of multiple sclerosis

Headache

Volumn 49, Issue 10, 2009, Pages 1513-1520

  Doi, Hikaru ^a   Matsushita, Takuya ^a   Isobe, Noriko ^a   Ishizu, Takaaki ^a   Ohyagi, Yasumasa ^a   Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Anti aquaporin 4 antibody; Headache; Interferon beta; Migraine; Multiple sclerosis

Indexed keywords

AMITRIPTYLINE; ANTIBODY; AQUAPORIN 4 ANTIBODY; BETA1A INTERFERON; INTERFERON BETA SERINE; PROPRANOLOL; UNCLASSIFIED DRUG; VALPROIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MORBIDITY; MULTIPLE SCLEROSIS; POSTTRAUMATIC HEADACHE; PRIMARY HEADACHE; PRIORITY JOURNAL; PROPHYLAXIS; SECONDARY HEADACHE; TENSION HEADACHE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CELL LINE; FEMALE; HEADACHE DISORDERS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECURRENCE;

EID: 70349969586     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2009.01427.x     Document Type: Article

References (42)

1. Mcfarland HF, Martin R. Multiple sclerosis: A complicated picture of autoimmunity. Nat Immunol. 2007 8 : 913 919.
2. Freedman MS, Gray TA. Vascular headache: A presenting symptom of multiple sclerosis. Can J Neurol Sci. 1989 16 : 63 66.
3. Rolak LA, Brown S. Headaches and multiple sclerosis: A clinical study and review of the literature. J Neurol. 1990 237 : 300 302.
4. Pöllmann W, Erasmus L-P, Feneberg W, Then Bergh F, Straube A. Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology. 2002 59 : 636 639.
5. D'Amico D, La Mantia L, Rigamonti A, et al. Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia. 2004 24 : 980 984.
6. La Mantia L, D'Amico D, Rigamonti A, Mascoli N, Bussone G, Milanese C. Interferon treatment may trigger primary headaches in multiple sclerosis patients. Mult Scler. 2006 12 : 476 480.
7. Welch KMA, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: Cause or the burden of illness? Headache. 2001 41 : 629 637.
8. Knight YE, Goadsby PJ. The periaqueductal grey matter modulates trigeminovascular input: A role in migraine? Neuroscience. 2001 106 : 793 800.
9. Cao Y, Aurora SK, Nagesh V, Patel SC, Welch KM. Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology. 2002 59 : 72 78.
10. Rocca MA, Ceccarelli A, Falini A, et al. Brain gray matter changes in migraine patients with T2-visible lesions: A 3-T MRI study. Stroke. 2006 37 : 1765 1770.
11. Haas DC, Kent PF, Friedman DI. Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area. Headache. 1993 33 : 452 455.
12. Gee JR, Chang J, Dublin AB, Vijayan N. The association of brainstem lesions with migraine-like headache: An imaging study of multiple sclerosis. Headcahe. 2005 45 : 670 677.
13. Tortorella P, Rocca MA, Colombo B, Annovazzi P, Comi G, Filippi M. Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis. J Neurol Sci. 2006 244 : 137 141.
14. Fragoso YD, Brooks JBB. Two cases of lesions in brainstem in multiple sclerosis and refractory migraine. Headache. 2007 47 : 852 854.
15. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2003 2 : 117 127.
16. Kira J, Kanai T, Nishimura Y, et al. Western vs Asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders. Ann Neurol. 1996 40 : 569 574.
17. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999 53 : 1107 1114.
18. Cree BA, Goodin DS, Hauser SL. Neuromyelitis optica. Semin Neurol. 2002 22 : 105 122.
19. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002 125 : 1450 1461.
20. Yamasaki K, Horiuchi I, Minohara M, et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis: Clinical, neuroimaging and immunogenetic studies. Brain. 1999 122 : 1689 1696.
21. Ishizu T, Osoegawa M, Mei F-J, et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain. 2005 128 : 988 1002.
22. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet. 2004 364 : 2106 2112.
23. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005 202 : 473 477.
24. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 66 : 1485 1489.
25. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain. 2007 130 : 1206 1223.
26. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol. 1983 13 : 227 231.
27. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 1983 33 : 1444 1452.
28. Fukazawa T, Hamada T, Tashiro K, Moriwaka F, Yanagihara T. Acute transverse myelopathy in multiple sclerosis. J Neurol Sci. 1990 100 : 217 222.
29. Headache classification subcommittee of the international headache society: The international classification of headache disorder, 2nd edition. Cephalalgia. 2004 24 : S1 S160.
30. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997 120 : 2059 2069.
31. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1988 38 : 180 185.
32. Sakai F, Igarashi H. Prevalence of migraine in Japan: A nationwide survey. Cephalalgia. 1997 17 : 15 22.
33. Takeshima T, Ishizaki K, Fukuhara Y, et al. Population-based door-to-door survey of migraine in Japan: The Daisen study. Headache. 2004 44 : 8 19.
34. Bruno PP, Carpino F, Carpino G, Zicari A. An overview on immune system and migraine. Eur Rev Med Pharmacol Sci. 2007 11 : 245 248.
35. Ochi H, Mei F-J, Osoegawa M, et al. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b. J Neurol Sci. 2004 222 : 65 73.
36. Mei FJ, Osoegawa M, Ochi H, et al. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis. J Neurol Sci. 2006 246 : 71 77.
37. Munno I, Marinaro M, Bassi A, Cassiano MA, Causarano V, Centonze V. Immunological aspects in migraine: Increase of IL-10 plasma levels during attack. Headache. 2001 41 : 764 767.
38. Munno I, Centonze V, Marinaro M, et al. Cytokines and migraine: Increase of IL-5 and IL-4 plasma levels. Headache. 1998 38 : 465 467.
39. Fidan I, Yüksel S, Ýmir T, Irkeç C, Aksakal FN. The importance of cytokines, chemokines, and nitric oxide in pathophysiology of migraine. J Neuroimmunol. 2006 171 : 184 188.
40. Venero JL, Vizuete ML, Ilundáin AA, Machado A, Echevarria M, Cano J. Detailed localization of aquaporin-4 messenger RNA in the CNS: Preferential expression in periventricular organs. Neuroscience. 1999 94 : 239 250.
41. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006 63 : 390 396.
42. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006 63 : 964 968.